CollPlant Biotechnologies (CLGN) Gross Margin Growth (1y) (2018 - 2026)
CollPlant Biotechnologies (CLGN) Gross Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 372.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -5.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -165.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 236.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | -42,373.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -42,373.00 |
| Dec 31, 2025 | -15,415.00 |
| Sep 30, 2025 | 645,065.00 |
| Jun 30, 2025 | -391.05 Mn |
| Mar 30, 2025 | 54,697.00 |
| Dec 31, 2024 | 9,267.00 |
| Sep 30, 2024 | -670,000.00 |
| Jun 30, 2024 | -20,922.00 |
| Mar 31, 2024 | -48,106.00 |
| Dec 31, 2023 | -15,163.00 |
| Sep 30, 2023 | 14,220.00 |
| Jun 30, 2023 | 5,911.00 |
| Dec 31, 2022 | 6,988.00 |
| Sep 30, 2022 | 142.84 Mn |
| Jun 30, 2022 | -307.00 |
| Dec 31, 2021 | -12,786.00 |
| Sep 30, 2021 | -142.86 Mn |
| Jun 30, 2021 | 2,880.00 |
| Mar 31, 2021 | 7,189.00 |
| Dec 31, 2020 | 3,104.00 |